Efficacy and influencing factors of endoscopic retrograde cholangiopancreatography with biliary stent implantation in the treatment of elderly patients with malignant obstructive jaundice
CSTR:
Author:
Affiliation:

(Department of Gastroenterology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China)

Clc Number:

Fund Project:

This work was supported by theSpecial Project of Capital Health Development Research (2022-4-201313).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To investigate the efficacy of endoscopic retrograde cholangiopancreatography (ERCP) with biliary stent implantation in the treatment of elderly patients with malignant obstructive jaundice, and to analyze its influencing factors. Methods Clinical data of 132 elderly patients with malignant obstructive jaundice who received ERCP with biliary stent implantation in our hospital from March 2023 to April 2025 were collected. Postoperative efficacy was defined as poor when total bilirubin was decreased by ≤30% or increased at 3 d after surgery compared with preoperative level. The 132 patients were divided into a good efficacy group and a poor efficacy group. General data including preoperative peripheral blood T cell receptor (TCR) Shannon entropy index, prealbumin(PA), liver reserve function [indocyanine green retention rate at 15 min (ICGR15)] were compared between the 2 groups. SPSS 25.0 statistics was used for data processing, and t test or Chi-square test was applied for intergroup comparison. Multivariate stepwise conditional logistic regression analysis was employed to identify the influencing factors for early poor efficacy after ERCP with biliary stent implantation in elderly patients with malignant obstructive jaundice. Survival curve was drawn by Kaplan-Meier survival analysis, and the survival difference was compared between groups by Log-rank test. Results The total bilirubin level was (245.58±21.63) μmol/L before surgery and (151.82±19.35) μmol/L at 3 d after surgery in the 132 patients. There were 37 patients with a decrease of ≤ 30% and 4 patients with an increase in total bilirubin compared to preoperative levels. A total of 41 patients (31.06%) with poor efficacy were included in the poor efficacy group, and the remaining 91 patients were included in the good efficacy group. The poor efficacy group exhibited significantly lower intraoperative bile duct dilatation rate, preoperative TCR Shannon entropy index and PA, and higher preoperative ICGR15 compared with the good efficacy group (P<0.05). Multivariate stepwise conditional logistic regression analysis revealed that preoperative ICGR15 (OR=5.463,95%CI 3.537-8.439; P<0.05) was a risk factor for early poor efficacy in elderly patients with malignant obstructive jaundice after ERCP with biliary stent implantation, and intraoperative bile duct dilatation(OR=0.375,95%CI 0.163-0.644; P<0.05), preoperative TCR Shannon entropy index (OR=0.240,95%CI 0.104-0.613; P<0.05) and preoperative PA (OR=0.359,95%CI 0.156-0.632; P<0.05) were protective factors. With 6 months after surgery as the endpoint, 11 patients (26.83%) in the poor efficacy group and 10 patients (10.99%) in the good efficacy group died. The mean survival time was significantly shorter in the poor efficacy group than the good efficacy group [5.34 months (95%CI 4.967-5.716) vs 5.80 months (95%CI 5.676-5.929); P=0.015]. Conclusion Early poor efficacy is not uncommon after ERCP with biliary stent implantation in elderly patients with malignant obstructive jaundice. Low preoperative ICGR15, high TCR diversity, high PA and intraoperative bile duct dilatation may promote the early postoperative total bilirubin decline.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 27,2025
  • Revised:
  • Adopted:
  • Online: November 11,2026
  • Published:
Article QR Code